PAXLOVID Oral Antiviral — Vax-Before-Travel

PAXLOVID Oral Antiviral

Fact checked by Holly Lutmer PharmD

Jun 10

4 min read

Following 15-day Paxlovid Regimen, Long COVID Benefits Absent

Stanford Medicine researchers report short term Paxlovid regimen was safe

Fact checked by Robert Carlson, MD

May 24

3 min read

Paxlovid Rebound Cases Confirmed by CDC

Oral Paxlovid treatment can enable covid-19 rebound cases

high school basketball game players

Fact checked by Holly Lutmer PharmD

May 14

3 min read

Generic Paxlovid Coming to Low- and Middle-Income Countries

Paxlovid is a U.S. FDA Approved oral antiviral targeting COVID-19

Covid-19 therapeutics page from CHAI

Fact checked by Robert Carlson, MD

May 9

5 min read

Oral COVID-19 Therapy Offers Measurable Benefits

Strong scientific evidence indicates Paxlovid reduces the risk of COVID-19 related hospitalization

doctor speaking with patient

Fact checked by Robert Carlson, MD

Mar 21

4 min read

What is Paxlovid’s Absolute and Relative COVID-19 Risk Reduction

Paxlovid (Nirmatrelvir, plus ritonavir) found effective against non hospitalized COVID-19 patients

women pharamsist testing and treating